Tuesday 8 October |
| 08:00-19:00 | | Registration Reception Foyer (Level 3)
|
| 08:50-09:00 | | Welcome and Introduction by CME Officer Ballroom 2
|
| 08:50 | | Welcome and Introduction |
| 09:00-10:00 | | CME Symposium (1) Chair(s): Dr Dinesh Giri (Bristol, UK) & Dr Tarini Chetty (Edinburgh, UK) Ballroom 2
|
| 9:00 | | Role of genomics in Paediatric Endocrinology |
| 9:30 | | Mechanisms of Disease in Primary Adrenal Insufficiency |
| 10:00-10:30 | | CME Oral Communications 1 Chair(s): Dr Dinesh Giri (Bristol, UK) & Dr Tarini Chetty (Edinburgh, UK) Ballroom 2
|
| 10:00 | OC1.1 | Phenotypic diversity in siblings with a rare cause of Hypophosphataemic rickets |
| 10:15 | OC1.2 | A case of Kearns-Sayer Syndrome Presenting with Hypoglycaemia and Adrenal Insufficiency |
| 10:30-11:00 | | Tea & Coffee Break Ballroom 1
|
| 11:00-12:00 | | CME Symposium 2 Chair(s): Dr Dinesh Giri (Bristol, UK) & Dr Harriet Gunn (London, UK) Ballroom 2
|
| 11:00 | | Interpretation of abnormal thyroid function tests in children and adoloscents |
| 11:30 | | Decoding Bone Profile |
| 12:00-12:30 | | CME Oral Communications 2 Chair(s): Dr Dinesh Giri (Bristol, UK) & Dr Harriet Gunn (London, UK) Ballroom 2
|
| 12:00 | OC2.1 | Facial Asymmetry Revealing Hypothyroidism and Pituitary Hyperplasia in a Young Child |
| 12:15 | OC2.2 | 16 Years of Learning: The First Patient Treated with Asfotase Alfa for Perinatal Hypophosphatasia |
| 12:30-13:00 | | CSAC Trainee Representative Spey
|
| 12:40-13:30 | | Lunch and Exhibition Ballroom 1
|
| 13:30-14:30 | | CME Symposium 3 Chair(s): Dr Dinesh Giri (Bristol, UK) & Dr Elizabeth VanBoxel (Southampton, UK) Ballroom 2
|
| 13:30 | | Insulin resistance-mechanisms, conditions and management |
| 14:00 | | Diabetes in children and young adults – Getting it right first time |
| 14:30-15:00 | | CME Oral Communications 3 Chair(s): Dr Dinesh Giri (Bristol, UK) & Dr Elizabeth VanBoxel (Southampton, UK) Ballroom 2
|
| 14:30 | OC3.1 | Phenotypic features of two brothers with a rare X-linked insulin receptor substrate 4 (IRS4) mutation and the suspected role of IRS4 in the HPT axis |
| 14:45 | OC3.2 | Diabetes and deafness: not just Wolfrom |
| 15:00-15:30 | | Tea & Coffee Break Ballroom 1
|
| 15:30-16:00 | | CME Symposium 4 Chair(s): Dr Dinesh Giri (Bristol, UK) & Dr James Law (Nottingham, UK) Ballroom 2
|
| 15:30 | | Testicular disorders and future fertility |
| 16:00-16:30 | | CME Oral Communications 4 Chair(s): Dr Dinesh Giri (Bristol, UK) & Dr James Law (Nottingham, UK) Ballroom 2
|
| 16:00 | OC4.1 | Reassessing Pancreatectomy in Diffuse Congenital Hyperinsulinism: A Tale of Two Brothers with Homozygous KCNJ11 Variants |
| 16:15 | OC4.2 | An Unusual Presentation of Paediatric Sarcoidosis |
| 16:30-16:45 | | CME Officer Update & Conclusion Ballroom 2
|
| 16:30 | | CME Officer Update & Conclusion |
| 17:00-17:45 | | Satellite Symposium For more information please see the satellite programme
|
| 19:00-21:00 | | Civic Reception hosted by the The Rt Hon The Lord Provost and Glasgow City Council
|
Wednesday 9 October |
| 08:00-18:30 | | Registration Reception Foyer (Level 3)
|
| 09:00-09:10 | | Welcome and Introduction Chair(s): Renuka Dias (Birmingham, UK) & Guftar Shaikh (Glasgow, UK) Ballroom 2
|
| 09:20-10:50 | | Endocrine Oral Communications 1 Chair(s): Charlotte Elder (Sheffield, UK) & Tabitha Randell (Nottingham, UK) Ballroom 2
|
| 09:20 | OC5.1 | BRINP2 Gene Variants are Implicated in Severe Delayed Puberty Associated with Neurodevelopmental Phenotypes |
| 09:30 | OC5.2 | Minipuberty: A Golden Phase for Optimal Treatment. Recombinant Gonadotropin Therapy During Minipuberty in Males with Hypogonadotropic Hypogonadism: A Case Series |
| 09:40 | OC5.3 | Crinecerfont in Children and Adolescents with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency: Results from the Phase 3 CAHtalyst Pediatric Study |
| 09:50 | OC5.4 | Premature Adrenarche, Body Composition and Metabolic Dysfunction – A Pilot Study |
| 10:00 | OC5.5 | Glucocorticoid replacement therapy in congenital adrenal hyperplasia and its associations with growth outcomes - real world data analysis from an international cohort of 1500 patients. |
| 10:10 | OC5.6 | Diagnostic testing using gene panels for severe childhood growth failure and multiple pituitary hormone deficiency in England |
| 10:20 | OC5.7 | A novel human disorder: QSOX2 deficiency-induced growth restriction, gastrointestinal dysmotility and immune dysfunction highlights a new mechanism of disease. |
| 10:30 | OC5.8 | Oral risedronate therapy in Duchenne muscular dystrophy: The John Walton Muscular Dystrophy Centre Experience |
| 10:40 | OC5.9 | Genomic diagnoses in DSDs – 10-year experience from a regional DSD service |
| 09:20-10:50 | | CEW (Obesity) Symposium Chair(s): Senthil Senniappan (Liverpool, UK) and Neil Wright (Sheffield, UK) Ballroom 3
|
| 09:20 | | Bariatric surgery |
| 09:50 | | How do we work with young people who experience binge eating. |
| 10:20 | | What's new in obesity management? |
| 09:20-10:00 | | PENS Annual Meeting Spey
|
| 10:00-10:25 | | PENS BSPED Prize Spey
|
| 10:25-10:50 | | PENS Nurse Presentation Spey
|
| 10:25 | | PENS Nurse Presentation |
| 10:50-11:20 | | Tea & Coffee Break Ballroom 1
|
| 11:20-12:20 | | Endocrine Symposium 1 Chair(s): Dinesh Giri (Bristol, UK) & Faisal Ahmed (Glasgow, UK) Ballroom 2
|
| 11:20 | | Genetics of endocrine tumours |
| 11:50 | | Management of phaeochromocytoma and lessons for paediatricians |
| 11:20-12:20 | | Diabetes Symposium 1 Chair(s): Renuka Dias (Birmingham, UK) & Melanie Kershaw (Birmingham, UK) Ballroom 3
|
| 11:20 | | Screening in early T1D: Insights from ELSA |
| 11:50 | | Immunotherapy updates in T1D |
| 12:20-12:50 | | Endocrine Oral Communications 2 Chair(s): Senthil Senniappan (Liverpool, UK) & Angela Lucas-Herald (Glasgow, UK) Ballroom 2
|
| 12:20 | OC6.1 | DXA lean mass index as a predictor of loss of ambulation in Duchenne Muscular Dystrophy and potential biomarker to initiate osteoporosis therapy prior to fractures |
| 12:26 | OC6.2 | BSPED Audit of Clinical Standards for Differences of Sexual Development (DSD) |
| 12:32 | OC6.3 | Systematic review of cardiometabolic outcomes in young people with gender dysphoria and the impact of puberty blockers |
| 12:38 | OC6.4 | Low-level chromosomal mosaicism does not explain the spontaneous menarche seen in some women with 45,X Turner Syndrome |
| 12:44 | OC6.5 | Rare causes of Silver-Russell Syndrome frequently present with atypical features highlighting important implications for genetic testing and clinical management |
| 12:20-12:50 | | Diabetes Oral Communications 1 Chair(s): Chairs: Evelien Gevers (London, UK) & Rajeeb Rashid (Glasgow, UK) Ballroom 3
|
| 12:20 | OC7.1 | Does severity of DKA presentation associate with autoantibody status, deprivation or ethnicity - a two-centre retrospective cohort |
| 12:26 | OC7.2 | A regional audit of Diabetic Ketoacidosis (DKA) presentations at diagnosis of type 1 diabetes (T1DM) and DKA management. |
| 12:32 | OC7.3 | Glycaemic control of children and young people with Type 1 Diabetes fasting during Ramadan at a single London Paediatric Diabetes unit |
| 12:38 | OC7.4 | Short term outcomes for children with new onset diabetes and confirmed SARS-CoV-2 Infections – a case series |
| 12:44 | OC7.5 | Comparison of glycaemic control across different ethnic and socioeconomic groups in a cohort of children using hybrid closed loop systems |
| 12:50-14:05 | | Lunch Ballroom 1
|
| 13:05-13:50 | | Poster Tours Ballroom Foyer
|
| 13:00-13:45 | | Satellite Symposium (2) For more information please see the satellite programme
|
| 13:00-13:45 | | Satellite Symposium (3) For more information please see the satellite programme
|
| 14:05-14:35 | | James M Tanner Award Chair(s): Tabitha Randell (Nottingham, UK) & Renuka Dias (Birmingham, UK) Ballroom 2
|
| 14:45-15:45 | | How Do I? (Endocrine) Chair(s): Paul Dimitri (Sheffield, UK) and Avril Mason (Glasgow, UK) Ballroom 2
|
| 14:45 | | Assessment of low trauma fractures |
| 15:15 | | Approach to hypoglycaemia |
| 14:45-15:45 | | How Do I? (Diabetes) Chair(s): Fiona Regan (London, UK) & Karen Whyte (Glasgow, UK) Ballroom 3
|
| 14:45 | | Support exercise and sports performance in T1D |
| 15:15 | | Engage the disengaged teenager? |
| 15:45-16:15 | | Tea & Coffee Break Ballroom 1
|
| 16:15-16:45 | | Endocrine Oral Communications 3 Chair(s): Jarod Wong (Glasgow, UK) & Justin Davies (Southampton, UK) Ballroom 2
|
| 16:15 | OC8.1 | A RETROSPECTIVE ANALYSIS OF ANTI-TPO RESULTS IN INFANTS WITH AN ABNORMAL CONGENITAL HYPOTHYROIDISM NEONATAL SCREENING |
| 16:21 | OC8.2 | Thyroid dysfunction in patients diagnosed with neuroblastoma who received MIBG scans. |
| 16:27 | OC8.3 | Psychological and social characteristics of children and young people living with obesity in Portsmouth and Southampton |
| 16:33 | OC8.4 | Impact of specialist psychology provision and outcomes for a DSD service |
| 16:39 | OC8.5 | The effect of CFTR modulators on growth, body composition and bone health in children and adolescents with cystic fibrosis |
| 16:15-17:15 | | Clinical Update Chair(s): Zainab Mohammed (Birmingham, UK) & Helen Storr (London, UK) Ballroom 3
|
| | Fertility preservation and when to refer? (female fertility) |
| | Fertility preservation and when to refer? (male fertility) |
| 16:45-17:15 | | Personal Practice Session Chair(s): Catherine Peters (London, UK) & Amanda Peacock (Newcastle, UK) Ballroom 2
|
| | Management of abnormal TFTs - when to hold your nerve? |
| 17:30-18:30 | | BSPED's 2024 AGM Ballroom 2
|
| 19:30-23:59 | | Conference Dinner
|
Thursday 10 October |
| 08:00-16:45 | | Registration Reception Foyer (Level 3)
|
| 08:00-08:45 | | Satellite Symposium (4) For more information please see the satellite programme
|
| 09:00-10:30 | | Diabetes Symposium 2 Chair(s): Verghese Matthew (Hull, UK) & Vaiva Kuehne (Glasgow, UK) Ballroom 2
|
| 09:00 | | Type 2 diabetes and new pharmacology SGLT2? |
| 09:30 | | Past, present and future of Closed loops |
| 10:00 | | Bringing Technology into Diabetes Care- from Evidence to Policy |
| 09:00-10:30 | | Endocrine Symposium 2 (Nurses / Endocrine Professionals Session) Ballroom 3
|
| 09:00 | | Prader Willi Syndrome - Role of MDT Clinic |
| | A Guide to Growth Hormone Deficiency for New Endocrine Nurses |
| 10:30-10:40 | | Tea & Coffee Break Ballroom 1
|
| 10:40-12:10 | | Diabetes Oral Communications 2 Chair(s): Fiona Campbell (Leeds, UK) & Vaiva Kuehne (Glasgow, UK) Ballroom 2
|
| 10:40 | OC9.1 | Award-Winning Virtual Schools Training Package Creates Capacity to Enable 78% of Children to Access Hybrid Closed Loop Therapy |
| 10:50 | OC9.2 | Improving access to diabetes technology for CYP with Diabetes across NENC: a response to Poverty Proofing, the National Paediatric Diabetes Audit and the NHSE CORE20PLUS5. |
| 11:00 | OC9.3 | Tackling health inequalities, engagement opportunities and metabolic management in young adults living with diabetes – Transition Safe and Sound (TraSS), an NHS England pilot. |
| 11:10 | OC9.4 | Working Above and Below the Lines: Paediatric diabetes health care professionals’ experiences of safeguarding and child protection. |
| 11:20 | OC9.5 | Socioeconomic status influencing the cessation of insulin pump therapy in children with Type 1 Diabetes: a cohort study |
| 11:30 | OC9.6 | Does admission for stabilisation affect HbA1c? A Single Trust Study |
| 11:40 | OC9.7 | Improving equity of care within a paediatric diabetes service |
| 11:50 | OC9.8 | Understanding the lived experiences of the development and maintenance of Disordered Eating Behaviours (DEB) in Type 1 Diabetes (T1D) in paediatric diabetes care |
| 12:00 | OC9.9 | Young People and Parent or Carers Views on Type 2 Diabetes Mellitus Care in England and Wales – insights from the PREM survey report |
| 10:40-11:40 | | Oral Communications 4 (Endocrine Professionals) Chair(s): Indi Bannerjee (Manchester, UK) & James Law (Nottingham, UK) Ballroom 3
|
| 10:40 | OC10.1 | Health-related quality of life in severe obesity: Baseline PedsQL scores from two tier 3 paediatric weight management services |
| 10:49 | OC10.2 | The effect of lifestyle and pharmacological interventions on body composition in childhood obesity |
| 10:58 | OC10.3 | Increased Prevalence of Hypertension in Paediatric Turner Syndrome |
| 11:07 | OC10.4 | Education Of Sick Day Management Of Paediatric Adrenal Insufficiency: A National Survey Of Paediatric Endocrine Nurse Specialists |
| 11:16 | OC10.5 | Single-centre review of use of Gonadotrophin-Releasing Hormone Agonists – are we outliers? |
| 11:25 | OC10.6 | Audit of Pituitary Dysfunction Post Moderate to Severe Traumatic Brain Injury and Proposed Surveillance Guidance |
| 11:40-12:10 | | Oral Communications 5 (Presentation from Previous Award Winner) Ballroom 3
|
| 11:40 | | Establishing the incidence, prevalence and clinical features of ROHHAD syndrome in the UK |
| 11:50 | | CoMBAT Study: Clinical effects of Metformin on Bones in Adults with Type 1 diabetes mellitus (T1DM) |
| 12:00 | | Presentation Title TBC |
| 12:10-12:25 | | Tea & Coffee Break Ballroom 1
|
| 12:25-13:35 | | Plenary Chair(s): Suet Ching Chen (Glasgow, UK) & Phil Murray (Manchester, UK) Ballroom 2
|
| 12:25 | | Obesity and metabolic syndrome - what can paediatricians learn from our adult colleagues? |
| 12:55 | | Rare Disease Registries – Joining The Dots For Collaborative Research |
| 13:15 | | Lessons from Rare Diseases – Repurposing Drugs and beyond |
| 13:35-14:35 | | Lunch Ballroom 1
|
| 13:45-14:30 | | Poster Tours
|
| 13:50-14:35 | | Satellite Symposium (5) For more information please see the satellite programme
|
| 14:40-16:10 | | Diabetes Symposium 3 Chair(s): Tarini Chetty (Edinburgh, UK) & Noina Abid (Belfast, UK) Ballroom 2
|
| 14:40 | | Lessons to be learnt from the Scottish Diabetes Group |
| 15:10 | | Management of Rare Diabetes |
| 15:40 | | Diabetes in pregnancy and outcomes |
| 14:40-16:10 | | Endocrine Symposium 3 Chair(s): Rod Mitchell (Edinburgh, UK) and Raja Padidela (Manchester, UK) Ballroom 3
|
| 14:40 | | AI-Powered Breakthroughs in Paediatric Endocrinology |
| 15:10 | | Benchmarking in Paediatric Endocrinology |
| 15:40 | | Hypogonadism and effects on CVS disease |
| 16:15-16:30 | | BSPED 2024 Awards Ballroom 2
|
| 16:30-16:45 | | Close of Meeting Ballroom 2
|